Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
STRYBOL DE ZEVEN TORENTJES from Brugge, company number BE0425619766, closed financial year 2025 with a result of € -477 after tax. For that financial year STRYBOL DE ZEVEN TORENTJES recorded a gross margin of € 84,442 and equity of € 82,193. Compared with financial year 2024, the result moved from € 76,219 to € -477. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 82,193
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -477
▼ still € 76,219 profit in 2024
Profit after tax over the fiscal year.
€ 12,525
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 7,825.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 723,317
▼ 9% vs 2024
€ 68,300 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 1,117
Supplier invoices still open on the last day of the fiscal year.
€ 164
▲ € 157 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 145,722 | € 259,986 | € 153,243 | € 84,442 | ▼ 45% |
| Profit after taxes | € 147,751 | € 265,684 | € 76,219 | € -477 | ▼ € 76,696 |
| Equity | € 82,467 | € 82,651 | € 82,670 | € 82,193 | ▼ 1% |
| Total debts | € 147,835 | € 265,773 | € 879,871 | € 756,994 | ▼ 14% |
| Cash | € 144,195 | € 10,171 | € 14,673 | € 12,525 | ▼ 15% |
| Land & buildings | - | - | € 446,124 | € 431,499 | ▼ 3% |
| Retained profit | € 8,099 | € 8,283 | € 8,302 | € 7,825 | ▼ 6% |
| Dividend | € 147,500 | € 265,500 | € 76,200 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 0 | € 791,617 | € 723,317 | ▼ 9% |
| Balance sheet total | € 230,302 | € 348,424 | € 962,541 | € 839,187 | ▼ 13% |
Key figures of STRYBOL DE ZEVEN TORENTJES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to STRYBOL DE ZEVEN TORENTJES?
What happened at STRYBOL DE ZEVEN TORENTJES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 477 (▼ € 76,696 vs 2024). Source: NBB ↗
- STRYBOL WOUT PHARMA BV became a director. NBB
- STRYBOL IBEN PHARMA BV became a director. NBB
- New establishment in Brugge. KBO
- Start of the company according to the CBE. KBO
In short
From € 147,751 profit in 2022 to € 477 loss in 2025.
Paid € 165 in corporate taxes since 2022.
Best year ever: 2023, with € 265,684 profit.
Paid out € 489,200 in dividends to the owners in total.
A new publication or filing at STRYBOL DE ZEVEN TORENTJES? We notify you, reason included.
Follow STRYBOL DE ZEVEN TORENTJESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of STRYBOL PHARMA, Strybol Wout Pharma, Strybol Iben Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
STRYBOL DE ZEVEN TORENTJESBehind STRYBOL DE ZEVEN TORENTJES are STRYBOL WOUT PHARMA BV and STRYBOL IBEN PHARMA BV. The shares are held by STRYBOL PHARMA (100%), Strybol Wout Pharma (50%) and Strybol Iben Pharma (50%).
Directors
According to the 2025 annual accounts
Director · represented by Strybol Wout
Also active at: APOTHEEK SMEKENS, Strybol Invest, PHARMA 310505, Strybol Pharma Groep, Strybol De Berken, Strybol Sint-Gillis
since 2025
Director · represented by Strybol Iben
Also active at: APOTHEEK SMEKENS, Strybol Invest, PHARMA 310505, Strybol Pharma Groep, Strybol De Berken, Strybol Sint-Gillis
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Odegemstraat 29
8310 Brugge
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.619.766
- VAT number
- BE 0425.619.766
- Registered office
- Odegemstraat 29, 8310 Brugge
- Names & denominations
- STRYBOL DE ZEVEN TORENTJES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 1983
- Peppol
- Active · Active since 30 Jan 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers